Prokarium
PrivateLast Round
Corporate Funding
Dec 2, 2025
Total Funding Raised
$73.87M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Prokarium is a biotechnology company that develops microbial immunotherapies for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prokarium Comparables
Compare Prokarium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Actym Therapeutics | 83% | |
| Vaxiion Therapeutics | 82% | |
| Shaoxing Salvectors Biotechnology Ltd. | 81% | |
Prokarium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 2, 2025 | ||||
| Grant | Mar 14, 2024 | ||||
| Series C | Feb 9, 2023 | ||||
| Series B | Oct 27, 2020 | ||||
| Grant | Oct 8, 2019 | ||||
Series A | Feb 26, 2018 |
Key People
Founding team and executive leadership
Prokarium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series A |
| Flerie Invest | Series B, Series A, Series C |
| Innovate UK | Grant |
| SynbiCITE | Grant, Series C |
| Korea Investment Holdings | Series C |
| Biotechnology and Biological Sciences Research Council | Grant |
| Korea Investment Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Will present interim clinical data at the 2026 AUA Annual Meeting.
- Mar 13, 2026
Will present interim clinical data at the EAU Annual Congress in London.
Prokarium Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prokarium's valuation, stock price, and market status.